Search results for " Progesterone"

showing 10 items of 83 documents

The action of estrogens and progestogens in the young female breast

2018

Evidence from different sources sustains a pro-oncogenic role of hormones, estrogens and progestogens, on the breast. The issue is of interest for young women, who are exposed to the hormonal changes imposed by the ovarian cycle and, often, take hormones with contraceptive purposes. Experimental and clinical studies show that both estrogens and progesterone are involved in mammary development during puberty and lactation, the changes being observed across mammalian species, including humans. Estrogen receptors, and more particularly the alpha isoform, participate in molecular processes of stem cells differentiation and epithelial proliferation through paracrine actions implicating growth fa…

Adult0301 basic medicinemedicine.medical_specialtymedicine.drug_classEstrogen receptorBreast NeoplasmsContraceptives Oral HormonalYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerInternal medicinemedicineHumansBreastAromataseAromatase inhibitorbiologybusiness.industryObstetrics and GynecologyEstrogensmedicine.disease030104 developmental biologyEndocrinologyPremenopauseReceptors EstrogenReproductive MedicineEstrogenSelective estrogen receptor modulator030220 oncology & carcinogenesisbiology.proteinFemaleProgestinsReceptors Progesteronebusinesshormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugHormoneEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.

2008

AIMS: CD1a is a molecule belonging to the highly conserved group of CD1 proteins. Its expression in dendritic cells is related to the presentation of tumour-derived glycolipid antigens to T cells and, consequently, the development of a successful antitumour response. The aim was to investigate the presence of CD1a+ cells in both primary tumours and lymph nodes (LN) of a series of 35 invasive ductal carcinomas by both immunohistochemistry and reverse transcription-polymerase chain reaction. METHODS AND RESULTS: CD1a antigen was more expressed in N0 than N1 breast cancer (P < 0.0001) in both primary lesions and LN metastases and correlated positively and significantly with oestrogen (ER) (P =…

AdultCD4-Positive T-LymphocytesCarcinoma Ductal BreastDown-RegulationBreast NeoplasmsDendritic CellsCD8-Positive T-LymphocytesMiddle AgedCD1APrognosisImmunohistochemistryAntigens CD1Gene Expression Regulation NeoplasticReceptors EstrogenPredictive Value of TestsLymphatic MetastasisHumansFemaleReceptors ProgesteroneAged
researchProduct

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.

2011

Abstract The purpose of this work was to determine whether there are differences in PIK3CA mutation status and PTEN protein expression between primary and matched metastatic breast tumors as this could influence patient management. Paraffin sections of 50 μm were used for DNA extraction and slides of 3 μm for immunohistochemistry (IHC) and FISH. Estrogen receptor, progesterone receptor, and HER2 IHC were repeated in a central laboratory for both primary tumors and metastases. PTEN levels were assessed by IHC and phosphoinositide 3-kinase (PI3K) pathway mutations were detected by a mass spectroscopy–based approach. Median age was 48 years (range: 30–83 years). Tumor subtype included 72% horm…

AdultCancer Researchmedicine.medical_specialtyClass I Phosphatidylinositol 3-KinasesReceptor ErbB-2Breast Neoplasmsmedicine.disease_causeArticleMetastasisMetastasisPhosphatidylinositol 3-KinasesBreast cancerInternal medicineBreast CancermedicinePTENHumansPTEN lossReceptorneoplasmsPI3K/AKT/mTOR pathwayAgedAged 80 and overMutationbiologyPTEN PhosphohydrolaseMiddle Agedmedicine.diseaseMetastatic breast cancerEndocrinologyOncologyReceptors EstrogenMutationbiology.proteinCancer researchImmunohistochemistryFemalePIK3CA mutationsReceptors ProgesteroneSignal TransductionMolecular cancer therapeutics
researchProduct

Expression of hormonal receptors in osteosarcomas of the jaw bones: clinico-pathological analysis of 21 cases

2013

Background: Sexual hormones have an important role in many hormone-dependant tumors like breast and prostate carcinomas, and also a relationship has been found with bone metabolism and bone tumors. Some studies have demonstrated that the expression of hormonal receptors (HR) in osteosarcomas (OS) of long bones is associated with gender, histological grade, histological type, and possibly may be connection with pathogenesis and evolution. However, to our knowledge there are no studies of HR in osteosarcomas of craniofacial bones (OS-CF). Objectives: To assess the expression of hormonal receptors in OS-CF. Material and Methods: Twenty one cases of OS-CF were included in this study. Clinical o…

AdultMalePathologymedicine.medical_specialtyAdolescentmedicine.drug_classEstrogen receptorOdontologíaYoung AdultProgesterone receptormedicineHumansCraniofacialReceptorGeneral DentistryAgedOsteosarcomaOral Medicine and Pathologybusiness.industryResearchMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseJaw NeoplasmsCiencias de la saludAndrogen receptorReceptors EstrogenOtorhinolaryngologyReceptors AndrogenEstrogenUNESCO::CIENCIAS MÉDICASOsteosarcomaFemaleSurgeryReceptors ProgesteronebusinessProgressive disease
researchProduct

Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types.

2009

Cancer of the salivary gland is one of the common cancers in the head and the neck regions. This type of cancer develops in the minor and the major salivary glands, and it sometimes metastasizes to other organs, particularly the lung. Morphologic mimicry and similarity in the expression of steroid hormone receptors between salivary gland tumors and breast tumors are well-known phenomena and are occasionally debated in the field of surgical pathology. The expression of sex hormone receptors in some tumors suggests a role for these receptors in tumor pathogenesis and therapy. Previous studies of the expression of estrogens and progesterone receptors in salivary gland tumors have reported conf…

AdultMalePathologymedicine.medical_specialtyAdolescentmedicine.medical_treatmentAdenoma PleomorphicAdenocarcinomaPleomorphic adenomaNeoplasms Multiple PrimaryMajor Salivary GlandProgesterone receptormedicineHumansReceptorGeneral DentistryAgedAged 80 and overbusiness.industrySex hormone receptorMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Salivary Gland NeoplasmsImmunohistochemistrySteroid hormoneCarcinoma ex pleomorphic adenomaOtorhinolaryngologyReceptors EstrogenUNESCO::CIENCIAS MÉDICASAdenocarcinomaSurgeryFemalebusinessReceptors ProgesteroneMedicina oral, patologia oral y cirugia bucal
researchProduct

Correlations of female steroid hormone receptors with histologic features in meningiomas.

1991

A series of 39 samples were obtained from meningiomas in 28 patients in order to investigate the relationships of the oestrogen receptor (OER) and progesterone receptor (PR) with the tumoural subtype and some histological features. Twenty-one samples were positive (greater than 10 fmole/mg protein), 7 were OER-PR-negative, and 1 was positive in both receptors. Twenty-two samples were considered as syncitial, 7 transitional, 7 fibroblastic and 3 angioblastic. The histological subtype was not found to be significantly related to the presence or absence of PR. Relations were not observed between the progestin receptor and the following histological parameters: cellular pattern, cell density, n…

AdultMalemedicine.medical_specialtyNecrosisPsammoma bodymedicine.drug_classmedicine.medical_treatmentMitosisMeningiomaNecrosisInternal medicineProgesterone receptormedicineMeningeal NeoplasmsHumansReceptorAgedbusiness.industryHistologyMiddle Agedmedicine.diseaseSteroid hormoneEndocrinologyReceptors EstrogenEstrogenSurgeryFemaleNeurology (clinical)medicine.symptombusinessMeningiomaReceptors ProgesteroneActa neurochirurgica
researchProduct

Estrogen and Progesterone hormone receptor expression in oral cavity cancer

2016

Background Recent studies have shown an increase in the incidence of oral squamous cell carcinoma (OSCC) in younger patients. The hypothesis that tumors could be hormonally induced during pregnancy or in young female patients without the well-known risk factors alcohol or tobacco abuse seems to be plausible. Material and Methods Estrogen Receptor alpha (ERα) and Progesterone Receptor (PR) expression were analyzed in normal oral mucosa (n=5), oral precursor lesions (simple hyperplasia, n=11; squamous intraepithelial neoplasia, SIN I-III, n=35), and OSCC specimen. OSCCs were stratified in a young female (n=7) study cohort and older patients (n=46). In the young female study cohort three patie…

AdultMalemedicine.medical_specialtymedicine.drug_classOral cavityYoung Adult03 medical and health sciences0302 clinical medicinePregnancyInternal medicineHumansMedicineYoung adultGeneral DentistryProgesteroneMouth neoplasmPregnancyOral Medicine and Pathologybusiness.industryResearchIncidence (epidemiology)Mouth MucosaCancerEstrogens030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesEndocrinologyReceptors EstrogenOtorhinolaryngologyEstrogenHormone receptor030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellFemaleMouth NeoplasmsSurgeryReceptors Progesteronebusiness
researchProduct

Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 pati…

2007

&lt;i&gt;Objective:&lt;/i&gt; We aimed to investigate the existence of associations between well-established and newly recognized biological and phenotypic features of breast cancer involved in tumor progression and prognosis. &lt;i&gt;Methods:&lt;/i&gt; Ninety-eight cases of invasive breast cancer were assessed for the immunohistochemical expression of estrogen and progesterone receptors, Ki-67, HER2, Akt-1, and Notch-2, using the tissue microarray technique. Data regarding tumor histotype, histological grade, tumor size and lymph node status were collected for each patient and included in the analysis. &lt;i&gt;Results:&lt;/i&gt; Several significant associations between histological and/o…

AdultOncologyCA15-3medicine.medical_specialtybreast cancer immunophenotypic analysis Notch-2 Akt-1 HER2/neuReceptor ErbB-2Breast NeoplasmsSettore MED/08 - Anatomia PatologicaHER2/neuImmunophenotypingPathology and Forensic MedicineBreast cancerImmunophenotypingInternal medicineBiomarkers TumormedicineHumansReceptor Notch2Notch 2Molecular BiologyProtein kinase BAgedAged 80 and overTissue microarraybiologybusiness.industryCancerCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseReceptors EstrogenTissue Array Analysisbiology.proteinFemaleReceptors ProgesteronebusinessProto-Oncogene Proteins c-akt
researchProduct

p95HER-2 Predicts Worse Outcome in Patients with HER-2-Positive Breast Cancer

2006

AbstractBackground: The HER-2 receptor undergoes a proteolytic cleavage generating an NH2-terminally truncated fragment, p95HER-2, that is membrane-associated and tyrosine-phosphorylated. We have reported that p95HER-2, but not the full-length receptor, p185HER-2, correlated with the extent of lymph node involvement in patients with breast cancer and its expression was significantly enhanced in nodal metastatic tissue. These facts suggested an important role for p95HER-2 either as a marker or cause of metastasis and poor outcome in breast cancer. In this work, we have studied the prognostic value of p95HER-2 in breast cancer.Methods: Primary breast tumor tissues (n = 483) were from surgical…

AdultOncologyCancer ResearchPathologymedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsMetastasisBreast cancerRisk FactorsInternal medicineBiomarkers TumorTumor Cells CulturedmedicineCarcinomaHumansLymph nodeSurvival rateAgedAged 80 and overbusiness.industryCarcinoma Ductal BreastHazard ratioMiddle AgedPrognosismedicine.diseasePrimary tumorConfidence intervalSurvival RateCarcinoma Lobularmedicine.anatomical_structureReceptors EstrogenOncologyLymphatic MetastasisFemaleLymph NodesReceptors ProgesteronebusinessClinical Cancer Research
researchProduct

Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer

2007

Abstract Despite the recent consensus on the eligibility of adjuvant systemic therapy in patients with lymph node–negative breast cancer (NNBC) based on clinicopathologic criteria, specific biological markers are needed to predict sensitivity to the different available therapeutic options. We examined the feasibility of developing a genomic predictor of chemotherapy response and recurrence risk in 185 patients with NNBC using assembled arrays containing 2,460 bacterial artificial chromosome clones for scanning the genome for DNA copy number changes. After surgery, 90 patients received anthracycline-based chemotherapy, whereas 95 did not. Tamoxifen was administered to patients with hormone r…

AdultOncologyCancer Researchmedicine.medical_specialtyPathologyAnthracyclinemedicine.medical_treatmentGene DosageBreast NeoplasmsBiologyGene dosageBreast cancerPredictive Value of TestsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAnthracyclinesGenetic Predisposition to DiseaseIn Situ Hybridization FluorescenceBacterial artificial chromosomeChemotherapyChromosomes Human Pair 11Nucleic Acid HybridizationGenomic signatureMiddle Agedmedicine.diseaseReceptors EstrogenOncologyLymphatic MetastasisPredictive value of testsFemaleChromosome DeletionNeoplasm Recurrence LocalReceptors ProgesteroneTamoxifenmedicine.drugCancer Research
researchProduct